{
    "2021-03-18": [
        [
            {
                "time": "",
                "original_text": "【权益变动】康龙化成(03759-HK)获FMRLLC增持26.41万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "FMRLLC",
                        "增持",
                        "权益变动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】康龙化成(03759-HK)涨3.15%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "异动股",
                        "涨3.15%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药板块热度不减，双鹭、海思科、丽珠、人福、贝达、康龙化成均大涨",
                "features": {
                    "keywords": [
                        "创新药",
                        "板块热度",
                        "双鹭",
                        "海思科",
                        "丽珠",
                        "人福",
                        "贝达",
                        "康龙化成",
                        "大涨"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：一体化CRO+CDMO服务平台深化融合 全球化发展立身科技前沿",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "CRO",
                        "CDMO",
                        "服务平台",
                        "全球化发展",
                        "科技前沿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}